Afatinib treatment of a squamous lung cancer after tumor progression of nivolumab

Nivolumab prolonged disease control in a patient with advanced squamous lung cancer that was refractory to multiple treatments. The rapid eradication of cancer after the administration of nivolumab caused hemoptysis and repeated infection. Six months after immunotherapy, mediastinal lymph node metas...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yinghua, Jiang, Qiuying, Xin, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754313/
https://www.ncbi.nlm.nih.gov/pubmed/29027754
http://dx.doi.org/10.1111/1759-7714.12522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754313/
https://www.ncbi.nlm.nih.gov/pubmed/29027754
http://dx.doi.org/10.1111/1759-7714.12522

Ejemplares similares